Saturday 17 October 2026
Export MTD’s income statement to Excel — free account
Mettler-Toledo International, Inc.
MTD Healthcare Diagnostics & Research
Mettler-Toledo International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 3.98% from fiscal 2024. In the quarter to June 2026, revenue grew 4.48%, EPS grew 18.3%, free cash flow grew 33.0% and total debt fell 3.29%, each against the same quarter a year earlier. Member of the S&P 500.
1,622.29
16.75
−1.02%
Follow MTD
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
29.05 | 42.82 | 27.78 | 34.67 | 45.08 | 50.98 | 37.63 | 33.63 | 30.06 | 33.01 |
Piotroski F-Score |
8 | 6 | 6 | 7 | 6 | 7 | 6 | 6 | 7 | 5 |
P/S ratio |
4.47 | 5.91 | 4.86 | 6.48 | 8.82 | 10.56 | 8.39 | 7.00 | 6.71 | 7.14 |
Altman Z-Score |
7.97 | 8.67 | 8.45 | 9.29 | 11.09 | 12.08 | 10.59 | 9.88 | 10.60 | 10.23 |
P/FCF ratio |
33.21 | 40.16 | 33.13 | 38.40 | 42.84 | 48.77 | 44.54 | 30.80 | 29.98 | 33.86 |
Altman Z″-Score (non-manufacturers) |
7.48 | 7.10 | 7.75 | 8.04 | 8.40 | 8.05 | 8.88 | 9.51 | 10.77 | 10.42 |
Beneish M-Score |
(2.62) | (2.56) | (2.57) | (2.52) | (2.65) | (2.57) | (2.40) | (2.80) | (2.62) | (2.44) |
P/Operating CF |
72.99 | 97.52 | 71.82 | 96.62 | 108.50 | 162.82 | 108.29 | 94.24 | 97.56 | 127.38 |
P/B ratio |
25.75 | 29.42 | 24.17 | 46.32 | 96.29 | 229.01 | 1,326.17 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
4.76 | 6.21 | 5.15 | 6.84 | 9.22 | 10.98 | 8.88 | 7.53 | 7.21 | 7.65 |
EV/EBITDA |
19.70 | 24.68 | 19.69 | 25.18 | 32.24 | 37.03 | 28.08 | 23.77 | 22.33 | 24.77 |
EV/Operating CF |
25.90 | 32.79 | 26.76 | 34.09 | 39.27 | 44.94 | 40.51 | 29.55 | 28.84 | 32.25 |
EV/FCF |
35.39 | 42.23 | 35.12 | 40.53 | 44.80 | 50.74 | 47.14 | 33.13 | 32.24 | 36.32 |
Quick Ratio |
1.04 | 0.98 | 0.97 | 1.03 | 0.82 | 0.65 | 0.70 | 0.62 | 0.64 | 0.71 |
Current Ratio |
1.53 | 1.46 | 1.42 | 1.47 | 1.26 | 1.11 | 1.20 | 1.04 | 1.02 | 1.14 |
Net Debt/EBITDA |
1.21 | 1.21 | 1.12 | 1.33 | 1.41 | 1.44 | 1.55 | 1.67 | 1.56 | 1.68 |
Debt/Assets |
41.26% | 38.43% | 39.51% | 46.29% | 47.41% | 50.56% | 57.68% | 62.01% | 62.16% | 57.97% |
Debt/Equity |
2.06 | 1.79 | 1.75 | 3.07 | 4.72 | 9.81 | 81.25 | (13.88) | (15.87) | (91.05) |
Asset Turnover |
1.22 | 1.16 | 1.14 | 1.11 | 1.10 | 1.21 | 1.15 | 1.11 | 1.17 | 1.16 |
Operating CF/Net income |
1.20 | 1.37 | 1.10 | 1.08 | 1.20 | 1.18 | 0.98 | 1.22 | 1.12 | 1.10 |
Capex/Depreciation |
(1.80) | (1.52) | (1.59) | (1.08) | (0.91) | (0.96) | (1.07) | (0.86) | (0.83) | (0.85) |
Interest Coverage |
19.17 | 18.60 | 19.79 | 19.47 | 20.30 | 23.00 | 20.33 | 13.96 | 15.10 | 16.32 |
| 75.71% | 76.56% | 90.14% | 111.02% | 171.37% | 338.69% | 889.34% | (1,260.59%) | (623.59%) | (1,154.87%) | |
| 18.63% | 15.94% | 19.84% | 20.75% | 21.51% | 25.04% | 25.59% | 23.04% | 26.17% | 25.00% | |
ROIC |
28.69% | 27.65% | 29.51% | 30.26% | 32.18% | 35.43% | 36.22% | 36.26% | 38.54% | 33.91% |
Return on Tangible Assets |
44.03% | 38.16% | 49.82% | 50.83% | 59.36% | 83.39% | 86.73% | 92.53% | 108.44% | 86.04% |
Average Days of Receivables |
66.21 | 70.80 | 66.59 | 68.70 | 70.25 | 63.55 | 66.05 | 63.97 | 64.77 | 70.55 |
Research and Development Expense of Revenue |
4.75% | 4.71% | 4.81% | 4.78% | 4.54% | 4.57% | 4.52% | 4.89% | 4.89% | 4.95% |
Selling, General and Administrative Expense of Revenue |
29.72% | 29.17% | 27.69% | 27.23% | 26.59% | 25.39% | 23.94% | 23.87% | 24.18% | 24.79% |
Intangible Assets out of Total Assets |
0.30 | 0.30 | 0.29 | 0.27 | 0.27 | 0.29 | 0.28 | 0.28 | 0.29 | 0.27 |
Share Based Compensation of Revenue |
0.61% | 0.61% | 0.60% | 0.61% | 0.61% | 0.53% | 0.50% | 0.47% | 0.52% | 0.56% |
Graham Net Nets |
(0.07) | (0.06) | (0.07) | (0.06) | (0.05) | (0.05) | (0.06) | (0.09) | (0.08) | (0.08) |
Graham Number |
73.25 | 83.67 | 103.54 | 93.90 | 82.05 | 74.51 | 31.04 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
3.44% | 2.34% | 3.60% | 2.88% | 2.22% | 1.96% | 2.66% | 2.97% | 3.33% | 3.03% |
Free Cash Flow Yield |
3.01% | 2.49% | 3.02% | 2.60% | 2.33% | 2.05% | 2.25% | 3.25% | 3.34% | 2.95% |
Revenue per Share |
94.59 | 105.98 | 116.42 | 122.46 | 129.18 | 160.74 | 174.27 | 173.39 | 182.47 | 195.36 |
Operating CF per Share |
17.38 | 20.08 | 22.41 | 24.56 | 30.34 | 39.29 | 38.19 | 44.21 | 45.63 | 46.37 |
Capex per Share |
(4.66) | (4.49) | (5.34) | (3.90) | (3.74) | (4.49) | (5.37) | (4.78) | (4.82) | (5.20) |
Free Cash Flow per Share |
12.72 | 15.59 | 17.07 | 20.66 | 26.60 | 34.80 | 32.82 | 39.43 | 40.81 | 41.18 |
Cash per Share |
5.98 | 5.78 | 7.06 | 8.46 | 3.95 | 4.26 | 4.27 | 3.20 | 2.80 | 3.25 |
Shareholders Equity per Share |
16.40 | 21.28 | 23.40 | 17.13 | 11.84 | 7.41 | 1.10 | (6.86) | (5.98) | (1.15) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
16.40 | 21.28 | 23.40 | 17.13 | 11.84 | 7.41 | 1.10 | (6.86) | (5.98) | (1.15) |
Free Cash Flow |
337.22 | 400.87 | 430.47 | 507.53 | 635.31 | 804.90 | 738.23 | 861.39 | 866.08 | 848.65 |
Working Capital |
309.27 | 317.05 | 311.43 | 355.14 | 216.58 | 122.82 | 227.36 | 49.12 | 25.71 | 164.55 |
Capital Expenditures |
(123.53) | (115.45) | (134.54) | (95.92) | (89.39) | (103.93) | (120.84) | (104.49) | (102.27) | (107.12) |
Net Current Asset Value |
(835.05) | (995.80) | (982.92) | (1,258.89) | (1,474.97) | (1,886.02) | (2,092.51) | (2,275.29) | (2,172.98) | (2,373.61) |
EV/EBIT |
22.22 | 27.76 | 22.14 | 28.24 | 36.30 | 41.06 | 30.90 | 26.43 | 24.78 | 27.55 |
Capex to Sales |
0.05 | 0.04 | 0.05 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
Price to Operating Income |
20.85 | 26.40 | 20.88 | 26.76 | 34.72 | 39.46 | 29.20 | 24.57 | 23.04 | 25.69 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.12 | 0.11 | 0.12 | 0.12 | 0.12 | 0.14 | 0.15 | 0.15 | 0.16 | 0.15 |
Cash ROIC |
22.67% | 23.92% | 23.88% | 26.44% | 37.12% | 41.24% | 34.57% | 43.05% | 44.50% | 38.66% |
Accounts Receivable Turnover |
5.79 | 5.54 | 5.52 | 5.46 | 5.32 | 5.99 | 5.78 | 5.52 | 5.73 | 5.50 |
Accounts Payable Turnover |
7.42 | 7.32 | 6.87 | 6.63 | 7.11 | 6.89 | 6.13 | 6.68 | 7.26 | 6.78 |
Inventory Turnover |
4.91 | 4.81 | 4.77 | 4.67 | 4.49 | 4.34 | 3.76 | 3.74 | 4.25 | 4.48 |
Average Days of Payables |
49.98 | 53.24 | 57.36 | 53.45 | 49.97 | 64.42 | 57.19 | 49.64 | 50.93 | 59.50 |
Days of Inventory on Hand |
75.71 | 81.11 | 78.42 | 78.99 | 84.59 | 97.85 | 100.03 | 91.04 | 80.77 | 86.41 |
Average Receivables |
433.20 | 491.80 | 532.07 | 550.89 | 580.03 | 620.57 | 678.33 | 686.61 | 675.50 | 732.68 |
Average Payables |
144.33 | 157.11 | 182.13 | 191.12 | 180.70 | 224.36 | 262.72 | 231.47 | 213.13 | 241.24 |
Average Inventory |
218.22 | 238.72 | 262.11 | 271.55 | 285.95 | 356.08 | 428.12 | 413.78 | 364.07 | 364.75 |
Average Assets |
2,063.06 | 2,358.29 | 2,584.33 | 2,704.08 | 2,801.94 | 3,070.67 | 3,409.60 | 3,423.98 | 3,297.78 | 3,476.32 |
Average Common Equity |
507.70 | 491.11 | 568.67 | 505.42 | 351.73 | 227.05 | 98.11 | (62.57) | (138.41) | (75.26) |
Columns are period end dates